Why the study?
Does RASB therapy prevent atrial fibrillation recurrence after pulmonary vein isolation in patients with AF and hypertension?
Does RASB therapy prevent atrial fibrillation recurrence after pulmonary vein isolation in patients with AF and hypertension?
RASB therapy may reduce atrial fibrillation recurrence after pulmonary vein isolation specifically in patients with low-burden paroxysmal AF and hypertension.
No takes yet. Share an insight, caveat, or question.
May support RASB in low-burden AF post-PVI; hypothesis-generating and requires randomized confirmation before practice change.
Berkowitsch et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: